Arizona Oncology Opens Latest Practice in Scottsdale
By Christina Caldwell -
Wednesday Jun 22, 2022
Arizona Oncology, one of the largest cancer centers in the state with more than 70 physicians, has opened its newest location at 8415 N. Pima Rd., Suite 165, Scottsdale. The practice, joining Arizona Oncology’s 14 other statewide locations, includes 14 treatment chairs in a relaxing environment to treat patients with all types of cancer in a community setting.
The new, comprehensive cancer center provides state-of-the-art services in diagnostic imaging, genomic testing, genetic testing, chemotherapy, surgery and clinical trials. As a unique element, patients will have the opportunity to have a biopsy performed same day to eliminate the stressful process of waiting for an appointment while facing a cancer diagnosis.
“We know that a possible cancer diagnosis can be an anxiety-inducing experience, but Arizona Oncology considers it a privilege to face the cancer battle head-on with our patients,” said Donna Rains, Scottsdale Practice Administrator. “By conducting a biopsy on the same day of a patient’s appointment, we reduce wait times and speed up a diagnosis, which allows our providers to treat the cancer sooner, leading to better overall outcomes.”
The new Scottsdale location is equipped with best-in-care services, including medical oncology, hematology, breast surgery, on-site infusion, bone marrow biopsy, genetic counseling and nutritional support. The practice and is staffed with dedicated and highly trained physicians and medical teams who treat all types of cancer, including breast, lung, skin, pancreas, thyroid, liver and more. Arizona Oncology offers an integrated, team-oriented approach to provide care for all types of cancer and works with patients to determine an individualized treatment plan for the best possible outcomes.
Physician specialists at the Scottsdale location include Dr. Edgar D. Staren, Statewide Director of Breast Surgery Services and Surgical Oncologist, and Medical Oncologists and Hematologists Dr. Christopher Di Simone, Dr. Paul O’Neill, Dr. Sharon Ondreyco and Dr. Joseph Volk.
Arizona Oncology patients are additionally supported by a welcoming staff of certified nutritionists, lab specialists, pharmacists and other healthcare professionals that work together to create a seamless patient experience.
The Scottsdale office joins Arizona Oncology’s other statewide locations in Glendale, Goodyear, Green Valley, Phoenix, Prescott, Prescott Valley, Scottsdale and Tucson.
About Arizona Oncology
Arizona Oncology is one of the largest medical groups in Arizona, with more than 100 clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. Since its inception in 1998, Arizona Oncology has led with the philosophy that it’s beneficial to provide cancer therapies in a community setting, close to patients' homes and support systems. Arizona Oncology specializes in Medical, Gynecologic, and Radiation Oncology, Hematology, Breast Surgery, Colorectal Surgery, Urology, Research, Genetic Risk Assessment, and patient ancillary programs. The physicians and their staff treat patients in many communities throughout the state including Glendale, Goodyear, Green Valley, Phoenix, Prescott, Prescott Valley, Scottsdale, and Tucson.
Arizona Oncology is an affiliate of The US Oncology Network (The Network). This collaboration unites AO with more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. AO also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.